Reaction
Limb Deformity reporting signals
As of the last recalculation, Limb Deformity appears in 1,575 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is LEFLUNOMIDE (PRR 36.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Leflunomide | 244 | 36.3 | 36.4 |
| Naproxen Sodium Tablet, Coated | 31 | 30.8 | 30.9 |
| Naproxen Sodium, Coated Tablets | 31 | 30.8 | 30.9 |
| Naproxen Sodium 220Mg | 31 | 30.8 | 30.9 |
| Tocilizumab | 195 | 25.6 | 25.7 |
| Abatacept | 185 | 19.9 | 19.9 |
| Hydroxychloroquine Sulfate | 118 | 18.4 | 18.4 |
| Hydroxychloroquine | 97 | 18.2 | 18.3 |
| Acetaminophen And Codeine | 16 | 17.5 | 17.5 |
| Meperidine Hydrochloride | 12 | 17.3 | 17.4 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 26 | 16.3 | 16.4 |
| Sulfasalazine | 85 | 15.1 | 15.1 |
| Adalimumab-Fkjp | 50 | 14.7 | 14.7 |
| Adalimumab-Aaty | 50 | 14.4 | 14.4 |
| Indomethacin | 14 | 14.1 | 14.1 |
| Captopril | 10 | 13.8 | 13.8 |
| Adalimumab-Adaz | 51 | 13.2 | 13.2 |
| Zidovudine | 13 | 12.9 | 13.0 |
| Desoximetasone | 17 | 11.9 | 11.9 |
| Misoprostol | 8 | 10.9 | 10.9 |
| Asfotase Alfa | 8 | 10.6 | 10.6 |
| Methotrexate | 282 | 10.6 | 10.6 |
| Zoledronic Acid | 31 | 10.4 | 10.4 |
| Methotrexate Sodium | 310 | 10.3 | 10.3 |
| Tofacitinib | 130 | 10.1 | 10.1 |
| Etanercept | 344 | 9.4 | 9.4 |
| Escitslopram | 39 | 9.1 | 9.1 |
| Efavirenz | 7 | 8.3 | 8.3 |
| Adalimumab | 314 | 7.1 | 7.1 |
| Golimumab | 42 | 6.6 | 6.6 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 6.1 | 6.1 |
| Orlistat | 10 | 5.1 | 5.1 |
| Certolizumab Pegol | 43 | 5.0 | 5.0 |
| Somatropin | 26 | 4.7 | 4.7 |